https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-04-28 / Eur J Cancer 2022 Jul;169:20-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-04-28 / Eur J Cancer 2022 Jul;169:20-312022-04-28 00:00:002022-04-28 00:00:00Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-04-28 / J Cancer Res Clin Oncol 2023 Apr;149(4):1425-1441
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-04-28 / J Cancer Res Clin Oncol 2023 Apr;149(4):1425-14412022-04-28 00:00:002022-04-28 00:00:00Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-04-05 / PLoS One 2022;17(4):e0264896
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-04-05 / PLoS One 2022;17(4):e02648962022-04-05 00:00:002022-04-05 00:00:00Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model
